ArticleAME case reports2026
Prenatal ultrasound diagnosis of fetal cervicofacial lymphangioma: a case report.
Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prenatal diagnosis of fetal cervicofacial lymphangioma is rare, and the diagnosis of the disease can be achieved through prenatal ultrasound. Due to the significant variation in the nature of fetal neck masses, the diagnostic process is challenging in cases involving this location. Nevertheless, we have successfully reported one such case using conventional two-dimensional and three-dimensional sonography. Case Description: A 27-year-old woman underwent routine fetal ultrasound at 20 weeks of gestation. Conventional two-dimensional ultrasound revealed a mixed cystic-solid mass located in the fetal neck and face. Three-dimensional ultrasound with surface rendering clearly delineated the external protrusion of the mass demonstrating marked distortion and elevation of the facial and cervical contours. The prenatal imaging findings were consistent with a diagnosis of cervicofacial lymphangioma. Following termination of pregnancy, histopathological examination and immunohistochemical analysis of the post-abortion specimens further confirmed the diagnosis. Conclusions: Prenatal ultrasonography remains the primary modality for diagnosing fetal cervicofacial lymphangioma. The integration of three-dimensional ultrasound surface imaging enhances diagnostic accuracy by providing detailed morphological information, offering critical visual evidence to support the initial diagnosis. Chromosomal karyotyping and genetic testing serve as important adjuncts in the comprehensive prenatal evaluation. These assessments facilitate thorough counseling and enable timely clinical decision-making, which are essential for optimizing perinatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.